OneAscent Family Office LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, Holdings Channel reports. The fund bought 6,470 shares of the company’s stock, valued at approximately $831,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Frazier Financial Advisors LLC bought a new position in Merck KGaA in the 2nd quarter valued at about $25,000. Kilter Group LLC bought a new stake in shares of Merck KGaA during the second quarter worth approximately $62,000. Addison Advisors LLC bought a new stake in shares of Merck KGaA during the second quarter worth approximately $90,000. Hara Capital LLC bought a new stake in shares of Merck KGaA during the second quarter worth approximately $110,000. Finally, Comprehensive Financial Planning Inc. PA acquired a new position in shares of Merck KGaA in the second quarter valued at approximately $134,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $162.12 on Friday. The firm has a market cap of $20.95 billion, a P/E ratio of 24.75 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The business’s 50 day moving average is $162.47 and its 200-day moving average is $148.35.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
